LBA26 BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC)

Josep Tabernero, T. Yoshino, T.W. Kim, R. Yaeger, J. Desai, Harpreet Wasan, Eric Van Cutsem, Fortunato Ciardiello, Tim Maughan, C. Eng, J. Tie, M.E. Elez Fernandez, Sara Lonardi, Xiaosong Zhang, R. Chavira, T. Usari, E. Hahn, S. Kopetz